Header cover image

French (CAC) Biotech Industry Analysis

UpdatedJun 26, 2022
DataAggregated Company Financials
Companies38
  • 7D16.0%
  • 3M-19.1%
  • 1Y-41.0%
  • YTD-41.0%

The Biotech industry is up 16% in the last week, with Valneva up 59%. In the same time, Inventiva was down 6.3%. In contrast, the industry has lost 41% in the last 12 months. As for the next few years, earnings are expected to grow by 43% per annum.

Industry Valuation and Performance

Has the French Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 26 Jun 2022€4.7b€993.1m-€693,029,894.00126x
Tue, 24 May 2022€4.6b€990.3m-€689,689,666.00136.6x
Thu, 21 Apr 2022€5.0b€1.2b-€488,793,426.002.9x
Sat, 19 Mar 2022€5.5b€950.2m-€648,336,889.0017.7x
Mon, 14 Feb 2022€5.4b€929.8m-€675,308,815.003x
Wed, 12 Jan 2022€6.3b€931.7m-€677,895,067.003.2x
Fri, 10 Dec 2021€6.9b€923.8m-€681,836,418.002.8x
Sun, 07 Nov 2021€6.6b€923.9m-€679,362,761.002.3x
Tue, 05 Oct 2021€6.7b€902.9m-€737,996,556.002.7x
Thu, 02 Sep 2021€7.8b€899.6m-€600,532,159.122.9x
Sat, 31 Jul 2021€6.6b€899.6m-€600,532,159.122.6x
Tue, 04 May 2021€7.2b€882.0m-€570,006,611.923.1x
Fri, 05 Feb 2021€7.1b€911.8m-€514,619,691.4222.3x
Mon, 09 Nov 2020€4.7b€737.3m-€578,081,678.948.7x
Sun, 02 Aug 2020€4.1b€624.3m-€569,407,653.4429.7x
Wed, 06 May 2020€5.0b€608.4m-€585,561,414.9618.8x
Sat, 08 Feb 2020€4.4b€548.6m-€625,688,103.6716.8x
Fri, 01 Nov 2019€3.4b€544.8m-€607,268,613.1056.4x
Mon, 05 Aug 2019€4.3b€547.0m-€661,534,274.6038.9x
Median PE Ratio

35.6x


Total Market Cap: €4.2bTotal Earnings: -€661,534,274.60Total Revenue: €547.0mTotal Market Cap vs Earnings and Revenue0%0%0%
French Biotech Industry Median PE3Y Average 21.8x202020212022
Current Industry PE
  • Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry's 3-year average PS ratio 6.9x is higher than the industry's current PS ratio of 4.7x.
Past Earnings Growth
  • Losses for companies in the Biotechnology industry have mostly stayed the same over the last three years.
  • Meanwhile revenues for these companies have grown 22% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, losses haven't seen much improvement.

Industry Comparison

How does French Biotech compare with similar industries?

FR Market3.63%
Healthcare6.69%
Biotech15.95%
Biotech15.95%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VLA Valneva€12.6559.4%
+€507.9m
17.6%PS3.9x
DBV DBV Technologies€4.4810.5%
+€39.8m
-53.2%PS83.4x
ALCLS Cellectis€2.8215.7%
+€19.6m
-78.2%PS3.7x
ALERS Eurobio Scientific Société anonyme€20.048.9%
+€17.7m
7.2%PS3.6x
ABVX ABIVAX Société Anonyme€11.306.8%
+€12.1m
-64.4%PB5.3x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

VLA

€12.65

Valneva

7D

59.4%

1Y

17.6%

ALBPS

€0.11

Biophytis

7D

-2.9%

1Y

-88.1%

NANO

€3.70

Nanobiotix

7D

-0.9%

1Y

-68.7%

ALSEN

€0.39

Sensorion

7D

-4.9%

1Y

-79.1%

POXEL

€1.58

Poxel

7D

-2.7%

1Y

-77.6%

ALCLS

€2.82

Cellectis

7D

15.7%

1Y

-78.2%

ALNOV

€1.70

Novacyt

7D

8.6%

1Y

-57.8%

GNRO

€2.47

GeNeuro

7D

-1.6%

1Y

-32.5%